Abstract
The synthesis of a series of andrographolide derivatives was described and their inhibitory effects on COX-2 expression in mouse macrophages were also evaluated. Some of the tested compounds showed better inhibitory potency than andrographolide, and compound (5d) was the best one.
Keywords: Andrographolide, Derivatives, COX-2, Expression, Inhibitory activity
Letters in Drug Design & Discovery
Title: Synthesis and Preliminary COX-2 Expression Inhibitory Activities of Andrographolide Derivatives
Volume: 7 Issue: 3
Author(s): Jing Li, Wenlong Huang, Huibin Zhang and Huiping Zhou
Affiliation:
Keywords: Andrographolide, Derivatives, COX-2, Expression, Inhibitory activity
Abstract: The synthesis of a series of andrographolide derivatives was described and their inhibitory effects on COX-2 expression in mouse macrophages were also evaluated. Some of the tested compounds showed better inhibitory potency than andrographolide, and compound (5d) was the best one.
Export Options
About this article
Cite this article as:
Li Jing, Huang Wenlong, Zhang Huibin and Zhou Huiping, Synthesis and Preliminary COX-2 Expression Inhibitory Activities of Andrographolide Derivatives, Letters in Drug Design & Discovery 2010; 7 (3) . https://dx.doi.org/10.2174/157018010790596614
DOI https://dx.doi.org/10.2174/157018010790596614 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Gene Therapy in Lung Transplantation
Current Gene Therapy HIV: A Raft-Targeting Approach for Prevention and Therapy Using Plant-Derived Compounds (Review)
Current Drug Targets Serotonergic Integration In the Intestinal Mucosa
Current Pharmaceutical Design Role of Heart Rate Reduction in the Management of Myocarditis
Current Pharmaceutical Design Microbiota Regulation of Inflammatory Bowel Disease
Inflammation & Allergy - Drug Targets (Discontinued) Selection of Potential Pharmacological Targets in ALS Based on Whole- Genome Expression Profiling
Current Medicinal Chemistry The Linkage Between Inflammation and Immune Tolerance: Interfering with Inflammation in Cancer
Current Cancer Drug Targets Current Scenario and Future Prospect in the Management of COVID-19
Current Medicinal Chemistry Structural Insights into the IL12:IL12 Receptor Complex Assembly by Molecular Modeling, Docking, and Molecular Dynamics Simulation
Combinatorial Chemistry & High Throughput Screening Magnitude and Clinical Profile of Juvenile Idiopathic Arthritis in a Medical College Hospital of a Socio-economically Disadvantaged Country
Current Rheumatology Reviews Oncolytic Viruses Driven by Tumor-Specific Promoters
Current Cancer Drug Targets Pre-B Cell Colony Enhancing Factor/NAMPT/Visfatin in Inflammation and Obesity- Related Disorders
Current Pharmaceutical Design Chemokine Receptors as Specific Anti-Inflammatory Targets in Peripheral Nerves
Endocrine, Metabolic & Immune Disorders - Drug Targets Molecular Modeling, Synthesis and Pharmacological Evaluation of 1,3,4- Thiadiazoles as Anti-inflammatory and Analgesic Agents
Medicinal Chemistry Multicomponent Pharmaceutical Cocrystals: A Novel Approach for Combination Therapy
Mini-Reviews in Medicinal Chemistry A Single Fas Gene Mutation Changes Lupus Onset, Severity, Location, and Molecular Abnormalities in Mice
Current Molecular Medicine Endoplasmic Reticulum Stress-induced Transcriptional Factor CHOP and Cardiovascular Diseases
Current Hypertension Reviews Central and Peripheral Pain Generators in Women with Chronic Pelvic Pain: Patient Centered Assessment and Treatment
Current Rheumatology Reviews The Role of Unbound Drug in Pharmacokinetics/Pharmacodynamics and in Therapy
Current Pharmaceutical Design Cardiovascular Disease and Dyslipidemia: Beyond LDL
Current Pharmaceutical Design